EUVIMEDEUVIMED entdecken
Crossref

Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome

Megan Lee, Molly Schiffer, Iris Isufi, Scott F Huntington iD, Mina L Xu iD, Tarsheen Sethi, Shalin K Kothari, Michael Girardi, Francine M Foss iD

British Journal of Haematology · 2025-11 · 207 (5) · 2140-2142

DOI: 10.1111/bjh.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 18.09.2025. Verfasst von Megan Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, Connecticut, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Sézary syndromebrentuximab vedotinimmunotoxinmycosis fungoidesperipheral sensory neuropathy

Autor:innen und Institutionen

  • Yale School of Medicine, New Haven, Connecticut, USA.
  • Yale-New Haven Hospital, New Haven, Connecticut, USA.
  • Hematology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology and Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Hematology, Yale Cancer Center, New Haven, Connecticut, USA.

ORCID-Profile: Scott F Huntington, Mina L Xu, Francine M Foss

Zitieren

APA

Lee, M., Schiffer, M., Isufi, I., Huntington, S. F., Xu, M. L., Sethi, T., Kothari, S. K., Girardi, M., & Foss, F. M. (2025). Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome. British Journal of Haematology, 207(5), 2140-2142. https://doi.org/10.1111/bjh.70147

Vancouver

Lee M, Schiffer M, Isufi I, Huntington SF, Xu ML, Sethi T, et al. Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome. British Journal of Haematology. 2025;207(5):2140-2142. doi:10.1111/bjh.70147

BibTeX
@article{Lee2025,
  author = {Lee, Megan and Schiffer, Molly and Isufi, Iris and Huntington, Scott F and Xu, Mina L and Sethi, Tarsheen and Kothari, Shalin K and Girardi, Michael and Foss, Francine M},
  title = {Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome},
  journal = {British Journal of Haematology},
  year = {2025},
  volume = {207},
  number = {5},
  pages = {2140--2142},
  doi = {10.1111/bjh.70147}
}
Kostenlos starten →